 |
|
Surprising rate of recurring heart attacks, strokes globally
August 31, 2009US doesn't fare as well as Japan and Australia
CHICAGO --- Despite many medicines and other treatments for patients with vascular disease, a large international study shows these patients have a surprisingly high rate of recurring events such as strokes, heart attacks and hospitalizations as well as mortality.
Also unexpected: patients in North America (including the U.S.) experienced an above-average rate of these events. Patients in Eastern Europe had the highest rate, and those in Australia and Japan had the lowest.
The results from the international REACH (Reduction of Atherothrombosis for Continued Health) Registry, presented by a researcher from Northwestern University Feinberg School of Medicine, examined data for 32,247 patients one and three years after they enrolled in the registry. Patients who had symptomatic vascular disease had a 14.4 percent rate at one year and 28.4 percent rate at three years of having a heart attack, stroke, rehospitalization for another type of vascular event or vascular death. Patients with vascular disease in more than one location of the body had the highest event rate at 40.5 percent at three years.
When projected over the global population who would mirror the patients in REACH, this represents millions of serious vascular events occurring every few years, many of which could be prevented.
"We were surprised by the high rate of these recurring vascular events," said lead author Mark J. Alberts, M.D., professor of neurology at the Feinberg School and director of the stroke program at Northwestern Memorial Hospital. "We know how to prevent vascular disease and the events that it produces. This points to the need for better prevention, better use of medications and a need to develop more potent medications. These are the number one and two causes of death throughout the world."
Vascular disease affects tens of millions of people in the U.S. and hundreds of millions globally, Alberts noted.
Alberts will present the results of the study at the European Society of Cardiology Congress 2009 in Barcelona on Aug. 31. A paper will be published simultaneously in the European Heart Journal.
Many of the patients in the REACH study were taking the appropriate medications for their vascular disease. "But that doesn't mean the medications worked or were being adhered to properly," Alberts said. "Perhaps they need more or different medications."
He said this study shows the need for more patients to adopt healthier lifestyles with increased exercise, a healthy diet and smoking cessation. These are inexpensive approaches to reducing and preventing the occurrence of vascular events.
Recurring vascular events cost billions of dollars annually in the U.S. The cost of heart attacks, angina or related conditions in the U.S. is $150 billion, of which 60 percent is related to hospitalization. The annual cost of these conditions in Germany is 3.3 billion Euros and in Italy, 3.1 billion Euros.
Between 19 percent and 33 percent of patients were rehospitalized for a vascular event other than a recurrent stroke, heart attack or vascular death. Since hospitalization is a major driving factor in health care costs, any steps to reduce the rate of hospitalization would have a positive impact on reducing health care expenses.
Northwestern University
The results from the international REACH (Reduction of Atherothrombosis for Continued Health) Registry, presented by a researcher from Northwestern University Feinberg School of Medicine, examined data for 32,247 patients one and three years after they enrolled in the registry. Patients who had symptomatic vascular disease had a 14.4 percent rate at one year and 28.4 percent rate at three years of having a heart attack, stroke, rehospitalization for another type of vascular event or vascular death. Patients with vascular disease in more than one location of the body had the highest event rate at 40.5 percent at three years.
When projected over the global population who would mirror the patients in REACH, this represents millions of serious vascular events occurring every few years, many of which could be prevented.
"We were surprised by the high rate of these recurring vascular events," said lead author Mark J. Alberts, M.D., professor of neurology at the Feinberg School and director of the stroke program at Northwestern Memorial Hospital. "We know how to prevent vascular disease and the events that it produces. This points to the need for better prevention, better use of medications and a need to develop more potent medications. These are the number one and two causes of death throughout the world."
Vascular disease affects tens of millions of people in the U.S. and hundreds of millions globally, Alberts noted.
Alberts will present the results of the study at the European Society of Cardiology Congress 2009 in Barcelona on Aug. 31. A paper will be published simultaneously in the European Heart Journal.
Many of the patients in the REACH study were taking the appropriate medications for their vascular disease. "But that doesn't mean the medications worked or were being adhered to properly," Alberts said. "Perhaps they need more or different medications."
He said this study shows the need for more patients to adopt healthier lifestyles with increased exercise, a healthy diet and smoking cessation. These are inexpensive approaches to reducing and preventing the occurrence of vascular events.
Recurring vascular events cost billions of dollars annually in the U.S. The cost of heart attacks, angina or related conditions in the U.S. is $150 billion, of which 60 percent is related to hospitalization. The annual cost of these conditions in Germany is 3.3 billion Euros and in Italy, 3.1 billion Euros.
Between 19 percent and 33 percent of patients were rehospitalized for a vascular event other than a recurrent stroke, heart attack or vascular death. Since hospitalization is a major driving factor in health care costs, any steps to reduce the rate of hospitalization would have a positive impact on reducing health care expenses.
Northwestern University
Vascular Disease Current Events and Vascular Disease News RSSAdding ezetimibe to atorvastatin improves lipid control
Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone.
Obesity may hinder optimal control of blood pressure and cholesterol
Obese patients taking medications to lower their blood pressure and cholesterol levels are less likely to reach recommended targets for these cardiovascular disease risk factors than their normal weight counterparts, according to new research presented at the 2009 Canadian Cardiovascular Congress hosted by the Canadian Cardiovascular Society and the Heart and Stroke Foundation of Canada.
BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease
Researchers from Boston University School of Medicine (BUSM) in collaboration with researchers from Lahey Clinic Northshore, Peabody, Mass., believe that androgen deficiency might be the underlying cause for a variety of common clinical conditions, including diabetes, erectile dysfunction, metabolic syndrome and cardiovascular disease (CVD).
Radiologists find a technique to significantly reduce patient radiation dose during CT angiography
Radiologists have discovered that prospective electrocardiogram (ECG) gating allows them to significantly reduce the patient radiation dose delivered during computed tomography (CT) angiography, a common noninvasive technique used to evaluate vascular disease.
Many Australians at risk of cardiovascular disease are not receiving best practice care
Many people are not receiving the best possible care when it comes to managing cardiovascular conditions according to two new Australian research studies.
Link between depression, early stages of chronic kidney disease found by researchers
One in five patients with chronic kidney disease is depressed, even before beginning long-term dialysis therapy or developing end-stage renal disease, UT Southwestern Medical Center researchers have found.
Team reveals molecular mechanism underlying a form of diabetes
By investigating a rare and severe form of diabetes in children, University of Iowa researchers have discovered a new molecular mechanism that regulates specialized pancreatic cells and insulin secretion.
Aspirin works for primary prevention in moderate and high risk diabetics
The beneficial effects of aspirin in primary prevention of cardiovascular events i.e. stroke, MI and cardiac death are known and generally accepted.
Elevated arginase levels contribute to vascular eye disease such as diabetic retinopathy
Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.
Made-to-measure solutions for enhancing prostheses of amputated legs
TECNALIA Corporación Tecnológica and the Valencia Institute for Biomechanics (IBV) have designed made-to-measure solutions to improve adaptation to replacements for amputated legs - the prime objective of the new health biomaterials project, FABIO, financed by the Ministry of Industry, Trade and Tourism.
More Vascular Disease Current Events and Vascular Disease News Articles
 |
Handbook of Patient Care in Vascular Diseases (Lippincott Williams & Wilkins Handbook) by Todd E Rasmussen (Author), W. Darrin Clouse (Author), Britt H Tonnessen (Author) Completely revised by a team of new authors with expertise in endovascular procedures, this handbook is a quick reference for the effective treatment of patients with common arterial and venous diseases. In concise outline format, the book covers all major vascular disorders, including peripheral vascular diseases, and emphasizes patient management issues rather than step-by-step surgical procedures. This Fifth Edition covers common endovascular procedures and their preoperative and postoperative management issues. A major section provides disease-specific care outlines for various vascular disease categories, with references to the contemporary literature. From diagnosis to follow-up, each chapter includes indications for therapy, periprocedural management, and valuable tips on avoiding... |
|
South African Journal of Diabetes and Vascular Disease by Clinics Cardive Publishing Co | |
 |
FlameEz-Vascular, 60 Capsules/Bottle by FlameEz Inflammation plays a key role in plaque building up in coronary arteries, which leads to heart disease and heart attack. At the early stage, the plaque can build up quickly in inflamed arteries. If inflammatory conditions persist, the plaque can expand rapidly causing blood vessel narrowing. In advanced stage, inflammation leads to development of "soft" plaque that can rupture suddenly and cause heart attack. For many, cardiovascular disease is a silent disease, with no visible signs or symptoms until it suddenly leads to a heart attack or stroke. It is widely accepted that control of inflammation may yield a more ‘stable’ plaque that less likely to rupture. However, there are currently no medications available for direct treatment of the underlying chronic inflammation associated... |
 |
Vascular Medicine - A Companion to Braunwald's Heart Disease Expert Consult Online and Print by Mark A. Creager (Author), Victor J. Dzau (Author), Joseph Loscalzo (Author) Tap into the latest knowledge and approaches to vascular medicine with the comprehensive, clinically oriented coverage of this new addition to the Braunwald’s Heart Disease family. You’ll find today’s best methods for identifying and treating arterial diseases of the limbs * renal, mesenteric and cerebral circulation problems * aortic aneurysms * vasospastic diseases * vasculitides * venous thromboembolisms * lymphedema * and much more. * Integrates a contemporary understanding of vascular biology with a thorough review of clinical vascular disease. * Covers the fundamental biology of blood vessels and the pathobiologic foundation of vascular disease. * Provides an in-depth, state-of-the-art review of all vascular diseases with emphasis on pathophysiology, diagnosis, and management.... |
 |
Cognitive Aging and Alzheimer's Disease: Gender Matters What is normal versus abnormal cognitive function in women, versus men, and how does dementia make itself known? What can be done to prevent Alzheimer's Disease? |
|
Diagnostic and Therapeutic Approaches to Vascular Disease [VHS] Starring: University of Washington School of Medicine | |
 |
Retinal Vascular Disease by A.M. Joussen (Editor), T.W. Gardner (Editor), B. Kirchhof (Editor), S.J. Ryan (Editor) Vascular diseases of the retina are a major cause of blindness among all age groups. Edited and written by internationally well-known experts, this state-of-the-art comprehensive overview of basic and clinical science will enhance the understanding of retinal vascular disease and help in the evaluation of current and future treatment approaches for the clinician. The well-structured and highly illustrated text is divided into the following three main sections: |
|
Vascular Disease Management by Hmp Communications | |
 |
Manual Of Vascular Diseases by Lippincott Williams & Wilkins Manual of Vascular Diseases : Manual of Vascular Diseases Pub Date: August 2004 Product Type: Print Author/s: Sanjay Rajagopalan MD; Debabrata Mukherjee MD, MS, FACC; Emile R Mohler III, MD This convenient and portable manual written by cross-disciplinary leading experts is a practical /"how-to/" guide which emphasizes management of vascular diseases. Designed for quick reference at the point of care, the manual provides easy access to information that is crucial for clinical decision making.Chapters succinctly describe the most effective diagnostic assessment and treatment strategies, including drug doses, protocols for patient management, and algorithms. The book also includes chapters on diagnostic aspects of lower extremity arterial disease, history and physical... |
 |
Mechanisms of Vascular Disease: A Textbook for Vascular Surgeons by Robert Fitridge (Editor), Matthew Thompson (Editor) This textbook provides an up-to-date account of the mechanisms and pathophysiology of vascular disease, and the current treatment options open to vascular surgeons. As the scientific basis of vascular disease advances rapidly, it is critical that clinicians have access to relevant information written specifically for vascular surgeons. This account reviews the impact of these scientific advances on established and emerging treatment options. Experts from Australia, North America and Europe have contributed to basic topics such as atherosclerosis, restenosis, thrombosis and hemostasis, ischaemia-reperfusion injury, sepsis, vascular hemodynamics and wound healing. More applied topics such as pain syndromes in vascular surgery and the diabetic foot are also covered in this textbook. This... |
| © 2009 BrightSurf.com |